176 related articles for article (PubMed ID: 37084069)
1. Successful allogeneic hematopoietic stem cell transplantation for myelodysplastic neoplasms complicated with secondary pulmonary alveolar proteinosis and Behçet's disease harboring GATA2 mutation.
Sato Y; Fukatsu M; Suzuki T; Sasajima T; Gunji N; Yoshida S; Asano N; Fukuchi K; Mori H; Takano M; Hayashi K; Takahashi H; Shirado-Harada K; Kimura S; Koyama D; Migita K; Ikezoe T
Int J Hematol; 2023 Nov; 118(5):642-646. PubMed ID: 37084069
[TBL] [Abstract][Full Text] [Related]
2. Intestinal Behçet's disease complicated by myelodysplastic syndrome and secondary pulmonary alveolar proteinosis: a case report.
Shimizu H; Sato S; Suzuki T; Sasajima T; Takahata Y; Shinohara N; Hideshima K; Yokokawa Y; Matsuhashi N; Ichii O; Tai M; Ejiri Y; Yano K; Ikezoe T; Ohira H; Migita K
BMC Gastroenterol; 2021 Dec; 21(1):488. PubMed ID: 34930121
[TBL] [Abstract][Full Text] [Related]
3. Donor-derived myelodysplastic syndrome after allogeneic stem cell transplantation in a family with germline GATA2 mutation.
Sakata N; Okano M; Masako R; Tanaka A; Yamashita Y; Karasuno T; Imadome KI; Okada M; Sugimoto K
Int J Hematol; 2021 Feb; 113(2):290-296. PubMed ID: 32865708
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow transplantation for Behçet's disease: a case report and systematic review of the literature.
Soysal T; Salihoğlu A; Esatoğlu SN; Gültürk E; Eşkazan AE; Hatemi G; Hatemi I; Öngören Aydın Ş; Erzin YZ; Başlar Z; Tüzüner N; Ferhanoğlu B; Çelik AF
Rheumatology (Oxford); 2014 Jun; 53(6):1136-41. PubMed ID: 24505123
[TBL] [Abstract][Full Text] [Related]
5. Clinical features of three cases with pulmonary alveolar proteinosis secondary to myelodysplastic syndrome developed during the course of Behçet's disease.
Handa T; Nakatsue T; Baba M; Takada T; Nakata K; Ishii H
Respir Investig; 2014 Jan; 52(1):75-9. PubMed ID: 24388375
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic stem cell transplantation for trisomy 8-positive myelodysplastic syndrome or myelodysplastic/myeloproliferative disease with refractory Behçet's disease: Case report and the review of literature.
Onaka T; Nakano K; Uemoto Y; Miyakawa N; Otsuka Y; Ogura-Kato A; Iwai F; Tanaka Y; Yonezawa A
Mod Rheumatol Case Rep; 2022 Jun; 6(2):273-277. PubMed ID: 35365826
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic hematopoietic cell transplantation in the management of GATA2 deficiency and pulmonary alveolar proteinosis.
van Lier YF; de Bree GJ; Jonkers RE; Roelofs JJTH; Ten Berge IJM; Rutten CE; Nur E; Kuijpers TW; Hazenberg MD; Zeerleder SS
Clin Immunol; 2020 Sep; 218():108522. PubMed ID: 32682923
[TBL] [Abstract][Full Text] [Related]
8. Optimal Treatment Approaches to Intestinal Behçet's Disease Complicated by Myelodysplastic Syndrome: The KASID and KSBD Multicenter Study.
Park JB; Han SJ; Lee SB; Kim DH; Cheon JH; Hwang SW; Ye BD; Yang SK; Park SJ; Park SH;
Yonsei Med J; 2024 May; 65(5):265-275. PubMed ID: 38653565
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Outcomes of Myeloablative Allogeneic Stem Cell Transplantation for Pediatric Patients with Bone Marrow Failure, Myelodysplastic Syndrome and Acute Myeloid Leukemia with and without Germline GATA2 Mutations.
Hofmann I; Avagyan S; Stetson A; Guo D; Al-Sayegh H; London WB; Lehmann L
Biol Blood Marrow Transplant; 2020 Jun; 26(6):1124-1130. PubMed ID: 32088370
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome.
Bortnick R; Wlodarski M; de Haas V; De Moerloose B; Dworzak M; Hasle H; Masetti R; Starý J; Turkiewicz D; Ussowicz M; Kozyra E; Albert M; Bader P; Bordon V; Cario G; Beier R; Schulte J; Bresters D; Müller I; Pichler H; Sedlacek P; Sauer MG; Zecca M; Göhring G; Yoshimi A; Noellke P; Erlacher M; Locatelli F; Niemeyer CM; Strahm B;
Bone Marrow Transplant; 2021 Nov; 56(11):2732-2741. PubMed ID: 34244664
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of GATA2-related myeloid neoplasms.
Hirabayashi S; Wlodarski MW; Kozyra E; Niemeyer CM
Int J Hematol; 2017 Aug; 106(2):175-182. PubMed ID: 28643018
[TBL] [Abstract][Full Text] [Related]
12. Secondary pulmonary alveolar proteinosis: a single-center retrospective study (a case series and literature review).
Zhang D; Tian X; Feng R; Guo X; Wang P; Situ Y; Xiao Y; Xu KF
BMC Pulm Med; 2018 Jan; 18(1):15. PubMed ID: 29368649
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents.
Wlodarski MW; Hirabayashi S; Pastor V; Starý J; Hasle H; Masetti R; Dworzak M; Schmugge M; van den Heuvel-Eibrink M; Ussowicz M; De Moerloose B; Catala A; Smith OP; Sedlacek P; Lankester AC; Zecca M; Bordon V; Matthes-Martin S; Abrahamsson J; Kühl JS; Sykora KW; Albert MH; Przychodzien B; Maciejewski JP; Schwarz S; Göhring G; Schlegelberger B; Cseh A; Noellke P; Yoshimi A; Locatelli F; Baumann I; Strahm B; Niemeyer CM;
Blood; 2016 Mar; 127(11):1387-97; quiz 1518. PubMed ID: 26702063
[TBL] [Abstract][Full Text] [Related]
14. MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestations.
McReynolds LJ; Yang Y; Yuen Wong H; Tang J; Zhang Y; Mulé MP; Daub J; Palmer C; Foruraghi L; Liu Q; Zhu J; Wang W; West RR; Yohe ME; Hsu AP; Hickstein DD; Townsley DM; Holland SM; Calvo KR; Hourigan CS
Leuk Res; 2019 Jan; 76():70-75. PubMed ID: 30578959
[TBL] [Abstract][Full Text] [Related]
15. Successful umbilical cord blood hematopoietic stem cell transplantation in pediatric patients with MDS/AML associated with underlying GATA2 mutations: two case reports and review of literature.
Mallhi K; Dix DB; Niederhoffer KY; Armstrong L; Rozmus J
Pediatr Transplant; 2016 Nov; 20(7):1004-1007. PubMed ID: 27416790
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and molecular characteristics of GATA2 related pediatric primary myelodysplastic syndrome].
An WB; Liu C; Wan Y; Chen XY; Guo Y; Chen XJ; Yang WY; Chen YM; Zhang YC; Zhu XF
Zhonghua Xue Ye Xue Za Zhi; 2019 Jun; 40(6):477-483. PubMed ID: 31340620
[No Abstract] [Full Text] [Related]
17. Systemic inflammatory autoimmune disease before allogeneic hematopoietic stem cell transplantation is a risk factor for death in patients with myelodysplastic syndrome or chronic myelomonocytic leukemia.
Tazoe K; Harada N; Makuuchi Y; Kuno M; Takakuwa T; Okamura H; Hirose A; Nakamae M; Nishimoto M; Nakashima Y; Koh H; Hino M; Nakamae H
Ann Hematol; 2024 Jun; 103(6):2059-2072. PubMed ID: 38662207
[TBL] [Abstract][Full Text] [Related]
18. GATA2 and marrow failure.
Fabozzi F; Strocchio L; Mastronuzzi A; Merli P
Best Pract Res Clin Haematol; 2021 Jun; 34(2):101278. PubMed ID: 34404529
[TBL] [Abstract][Full Text] [Related]
19. [Successful cord blood transplantation for myelodysplastic syndrome with Behçet disease-like refractory stomatitis and multiple ileocecal ulcerations].
Kazumoto H; Ueki T; Kitahara M; Uematsu N; Shishido T; Kirihara T; Sato K; Hiroshima Y; Sumi M; Ueno M; Ichikawa N; Kobayashi H
Rinsho Ketsueki; 2019; 60(10):1436-1442. PubMed ID: 31695004
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of myelodysplastic syndrome (MDS)-related intestinal Behçet's disease by up-front cord blood transplantation.
Nonami A; Takenaka K; Sumida C; Aizawa K; Kamezaki K; Miyamoto T; Harada N; Nagafuji K; Teshima T; Harada M
Intern Med; 2007; 46(20):1753-6. PubMed ID: 17938534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
